ZKHF 010
Alternative Names: ZKHF-010Latest Information Update: 01 Feb 2023
At a glance
- Originator Zhaoke Pharmaceutical (Hefei)
- Developer Lee's Pharmaceutical; Zhaoke Pharmaceutical (Hefei)
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preregistration Neuromuscular blockade
Most Recent Events
- 01 Feb 2023 Preregistration for Neuromuscular blockade is ongoing in China (unspecified route) (Lee's Pharmaceutical pipeline, February 2023)
- 10 Dec 2020 Preregistration for Neuromuscular blockade in China (unspecified route), prior to December 2020 (Lee's pharmaceutical pipeline, December 2020)
- 10 Dec 2020 Zhaoke Pharmaceutical (Hefei) submits application to regulatory authority for Neuromuscular blockade, prior to December 2020 (Lee's Pharmaceutical pipeline, December 2020)